A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Hypercholesterolemia, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, familial hypercholesterolemia, hereditary disease, hyperlipidemia, hyperlipoproteinemia, inborn errors of metabolism, metabolic disease	Recruiting	Phase 3	2025-02-06		NCT06568471

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Hasten Biopharmaceutical Co., Ltd.	2

18 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beijing Anzhen Hospital of Capital Medical University	Beijing	China	1
Beijing Luhe Hospital, Capital Medical Univeristy	Beijing	China	1
Beijing Tsinghua Changgeng Hospital	Beijing	China	2
Binzhou Medical University Hospital	Binzhou	China	10
Daqingshi People's Hospital	Daqing	China	1
Fuwai Hospital, CAMS & PUMC	Beijing	China	1
Guangdong Provincial People's Hospital	Guangzhou	China	59
Heze Municipal Hospital	Heze	China	7
Nanchang People's Hospital	Nanchang	China	2
Peking University First Hospital	Beijing	China	71
Qilu Hospital of Shandong University	Jinan	China	68
Shijiazhuang People's Hospital	Shijiazhuang	China	3
The 2nd Xiangya Hospital of Central South University	Changsha	China	1
The First Affiliated Hospital of Wenzhou Medical Univesity	Wenzhou	China	1
The Third Xiangya Hospital of Central South University	Changsha	China	18
Tianjin People's Hospital	Tianjin	China	4
West China Hospital of Sichuan University	Chengdu	China	68
Zibo municipal hospital	Zibo	China	5